Please use this identifier to cite or link to this item: http://dspace.univ-guelma.dz/jspui/handle/123456789/13194
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSAIDANI SARRA, AMIROUCHE RAYANE-
dc.date.accessioned2022-10-13T07:28:19Z-
dc.date.available2022-10-13T07:28:19Z-
dc.date.issued2022-
dc.identifier.urihttp://dspace.univ-guelma.dz/jspui/handle/123456789/13194-
dc.description.abstractIn this work, we performed a QSAR study on a series of propiophenone-derived Anti-HIV used against SARS-CoV-2. Descriptors were obtained by Dragon software, from molecules optimized by the Gaussian-integrated B3LYP/6-31G(d, p) functional. A model based on multiple linear regression (MLR), was developed by Molegro for the prediction of pIC50s of the set of twenty inhibitors. The statistical treatment performed by Minitab shows that the statistical parameters obtained for the calibration and validation sets (correlation coefficients R=0.92, determination coefficients R2=0.84 and prediction coefficients Q2= 0.84) highlight the quality and relevance of the calculated model. Rigorous validation was considered to judge the stability and predictive capacity of this model. The goodness of fit of the developed model was verified by plotting the calculated values against the observed ones (R02 = 0.84).en_US
dc.language.isofren_US
dc.publisherhttps://www.univ-guelma.dz/en_US
dc.subjectQSAR, SARS-CoV-2, RLM, IC50, Anti-HIVen_US
dc.titleInhibiteurs du SARS-CoV-2 : Relation Quantitative Structure-Activité (QSAR)en_US
dc.typeWorking Paperen_US
Appears in Collections:Master

Files in This Item:
File Description SizeFormat 
SAIDANI_SARRA_F5_1656804773.pdf1,32 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.